© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 90700 refers to the Diphtheria, Tetanus Toxoids, and Acellular Pertussis vaccine (DTaP), specifically designed for intramuscular administration in individuals who are younger than 7 years of age. This vaccine plays a crucial role in immunization by providing long-lasting immunity against three serious bacterial infections: diphtheria, tetanus, and pertussis (whooping cough). The term 'toxoid' refers to a toxin that has been rendered non-toxic but still retains the ability to stimulate an immune response. By introducing these toxoids into the body, the vaccine prompts the immune system to produce antibodies that can neutralize the actual toxins produced by the bacteria if encountered in the future. The DTaP vaccine is particularly significant as it not only protects against these diseases but also does so with a reduced risk of side effects, thanks to the acellular pertussis component. This component is a more purified version of the pertussis vaccine, which minimizes adverse reactions while still effectively stimulating the immune system. The administration of this vaccine is vital for young children, as they are at a higher risk for severe complications from these infections. Code 90700 specifically captures the supply of this immunization product, emphasizing its role in safeguarding the health of pediatric patients by ensuring they receive the necessary protection against these preventable diseases.
© Copyright 2025 Coding Ahead. All rights reserved.
The DTaP vaccine (CPT® Code 90700) is indicated for the immunization of individuals younger than 7 years against three significant bacterial infections. The specific indications for administering this vaccine include:
The administration of the DTaP vaccine involves several key procedural steps to ensure safety and efficacy. These steps include:
Post-procedure care for the DTaP vaccine involves monitoring the patient for any immediate adverse reactions, which may include mild fever, redness, swelling at the injection site, or irritability. Caregivers should be advised to apply a cool compress to the injection site to alleviate discomfort and to administer acetaminophen if necessary for fever or pain, following appropriate dosing guidelines. It is also essential to inform caregivers about the schedule for follow-up doses, as the DTaP vaccine is typically administered in a series of doses to ensure full immunization. The healthcare provider should document the administration of the vaccine in the patient's medical record, including the date, site of injection, and any reactions observed during the post-administration period.
| Short Descr | DTAP VACCINE < 7 YRS IM | Medium Descr | DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | Long Descr | Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), when administered to individuals younger than 7 years, for intramuscular use | Status Code | Excluded from Physician Fee Schedule by Regulation | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | O1G - Immunizations/Vaccinations | MUE | 1 | CCS Clinical Classification | 228 - Prophylactic vaccinations and inoculations |
| 25 | Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service: it may be necessary to indicate that on the day a procedure or service identified by a cpt code was performed, the patient's condition required a significant, separately identifiable e/m service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. a significant, separately identifiable e/m service is defined or substantiated by documentation that satisfies the relevant criteria for the respective e/m service to be reported (see evaluation and management services guidelines for instructions on determining level of e/m service). the e/m service may be prompted by the symptom or condition for which the procedure and/or service was provided. as such, different diagnoses are not required for reporting of the e/m services on the same date. this circumstance may be reported by adding modifier 25 to the appropriate level of e/m service. note: this modifier is not used to report an e/m service that resulted in a decision to perform surgery. see modifier 57 for significant, separately identifiable non-e/m services, see modifier 59. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | GA | Waiver of liability statement issued as required by payer policy, individual case | GP | Services delivered under an outpatient physical therapy plan of care | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | GZ | Item or service expected to be denied as not reasonable and necessary | JZ | Zero drug amount discarded/not administered to any patient | PD | Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days | Q1 | Routine clinical service provided in a clinical research study that is in an approved clinical research study | SL | State supplied vaccine |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-15 | Changed | Corrected short and medium descriptions per AMA corrections document dated 2013-01-15. |
| 2013-01-01 | Changed | Description Changed |
| 2011-01-01 | Changed | Short description changed. |
| 2008-01-01 | Changed | Code description changed. |
| 2007-01-01 | Changed | Code description changed. |
| 2005-01-01 | Changed | Code description changed. |
| 1994-01-01 | Added | First appearance in code book in 1994. |
Get instant expert-level medical coding assistance.